Skip to main content
Log in

Receptor alterations in manganese intoxicated monkeys

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The density of four different receptors and one marker of dopamine uptake sites were analyzed in monkey brains after manganese exposure (0.1 g manganese per month during 26 months, a dose comparable to that workers might inhale in dusty environments) by means of quantitative receptor autoradiography. The binding of3H-mazindol to the dopamine uptake sites was reduced by 75% in both the head of the caudate nucleus and putamen, while it remained unchanged in the other regions analyzed. The binding of the D1 receptor ligand3H-SCH 23 390 was reduced about 45% in the same areas as mazindol binding, while the density of D2 receptors was unaffected. The muscarinic acetylcholine receptors as well as GABAA receptors remained also unchanged in all brain areas analyzed after manganese exposure. Thus the dopaminergic neurons must be considered to be vulnerable to manganese concentrations attainable in the work environment. Our results also indicate that postsynaptic structures containing D1 receptors are sensitive while cells containing D2 receptors are either spared or compensated for by up-regulation of the number of receptors on remaining sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barone P, Tucci I, Parashos SA, Chase TN (1987) D-1 dopamine receptor changes after striatal quinolinic acid lesions. Eur J Pharmacol 138: 141–145

    Article  PubMed  Google Scholar 

  • Camps M, Cortés R, Gueye B, Probst A, Palacios JM (1989) Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28: 275–290

    Article  PubMed  Google Scholar 

  • Ceballos I, Lafon M, Javoy-Agid F, Hirsch E, Nicole A, Sinet PM, Agid Y (1990) Superoxide dismutase and Parkinson's disease. Lancet 335: 1035–1036

    Article  Google Scholar 

  • Cortés R, Gueye B, Pazos A, Probst A, Palacios JM (1989) Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28: 263–273

    Article  PubMed  Google Scholar 

  • Eriksson H, Mägiste K, Plantin LO, Fonnum F, Hedström KG, Theodorsson Norheim E, Kristensson K, Stålberg E, Heilbronn E (1987) Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch Toxicol 61: 46–52

    Article  PubMed  Google Scholar 

  • Floran B, Aceves J, Sierra A, Martinez-Fong D (1990) Activation of Dl dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 116: 136–140

    Article  PubMed  Google Scholar 

  • Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma Jr FJ, Sibley DR (1990) D1 and D2 dopamine-receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429–1432

    PubMed  Google Scholar 

  • Gillberg PG, Aquilonius SM (1985) Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography. Changes in amyotrophic lateral sclerosis. Acta Neurol Scand 72: 299–306

    PubMed  Google Scholar 

  • Gillberg P-G, Jossan SS, Askmark H, Aquilonius S-M (1986) Large-section cryomicrotomy for in vitro receptor autoradiography. J Pharmacol Methods 15: 169–180

    Article  PubMed  Google Scholar 

  • Goldstein M (1984) Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step. Ann NY Acad Sci 430: 1–5

    Google Scholar 

  • Graybiel AM, Moratalla R (1989) Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc Natl Acad Sci USA 86: 9020–9024

    PubMed  Google Scholar 

  • Hirsch EC, Graybiel AM, Agid Y (1989) Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease. Acta Neurol Scand Suppl 126: 19–22

    PubMed  Google Scholar 

  • Jossan SS, d'Argy R, Gillberg PG, Aquilonius SM, Långström B, Halldin C, Bjurling P, Stålnacke CG, Fowler J (1989) Localization of monoamine oxidase B in human brain by autoradiographical use of11C-labelled 1-deprenyl. J Neural Transm 77: 55–64

    Article  PubMed  Google Scholar 

  • Joyce JN, Marshall JF (1985) Striatal topography of D-2 receptors correlates with indexes of cholinergic neuron localization. Neurosci Lett 53: 127–131

    Article  PubMed  Google Scholar 

  • Joyce JN, Lexow N, Bird E, Winokur A (1988) Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2: 546–557

    Article  PubMed  Google Scholar 

  • Leenders KL, Aquilonius SM, Bergström K, Bjurling P, Crossman AR, Eckernäs SA, Gee AG, Hartvig P, Lundqvist H, Långström B, Rimland A, Tedroff J (1988) Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers. Brain Res 445: 61–67

    Article  PubMed  Google Scholar 

  • Lehmann J, Langer SZ (1983) The striatal cholinergic interneuron: synaptic target of dopaminergic terminals. Neuroscience 10: 1105–1120

    Article  PubMed  Google Scholar 

  • Lowenstein PR, Slesinger PA, Singer HS, Walker LC, Casanova MF, Raskin LS, Price DL, Coyle JT (1989) Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study. J Comp Neurol 288: 428–446

    Article  PubMed  Google Scholar 

  • Maura G, Giardi A, Raiteri M (1988) Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J Pharmacol Exp Ther 247: 680–684

    PubMed  Google Scholar 

  • Mena I, Marin O, Fuenzalida S, Cotzias GC (1967) Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17: 128–136

    PubMed  Google Scholar 

  • Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC (1970) Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane. N Engl J Med 282: 5–10

    PubMed  Google Scholar 

  • Pifl C, Beitel O, Schingnitz G, Hornykiewicz O (1990) Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurochemlnt 17: 263–270

    Article  Google Scholar 

  • Rodier J (1955) Manganese poisoning in Maroccan miners. Br J Ind Med 12: 21–35

    PubMed  Google Scholar 

  • Seeman P, Niznik HB (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 4: 2737–2744

    PubMed  Google Scholar 

  • Smith AD, Bolam JP (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. TINS 13: 259–265

    PubMed  Google Scholar 

  • Wang JD, Huang CC, Hwang YH, Chiang JR, Lin JM, Chen JS (1989) Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 46: 856–859

    PubMed  Google Scholar 

  • Zarbin MA, Wamsley JK, Palacios JM, Kuhar MJ (1986) Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina. Brain Res 374: 75–92

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eriksson, H., Gillberg, PG., Aquilonius, SM. et al. Receptor alterations in manganese intoxicated monkeys. Arch Toxicol 66, 359–364 (1992). https://doi.org/10.1007/BF01973632

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01973632

Key words

Navigation